Now livetag icon
Last chance: Join our AI Brand Visibility webinar with industry leaders Aleyda Solis and Rand Fishkin!Secure your spot nowbanner icon
Neurimmune

June 2026

Neurimmune Market Share Analysis for June 2026

Beschreibung für das Impressum
Year Founded2006
Employees51 - 200
Annual Revenue$2M - $5M
neurimmune.com
Neurimmune
Neurimmune (including company regionals)
  • neurimmune.com
    neurimmune.com
See more website traffic and engagement information

Neurimmune Revenue up to June 2026 is 2M - 5M

revenue generated by Neurimmune top domains

Neurimmune top domains revenue over 3 years

Revenue for Neurimmune top domains


Total visits to Neurimmune's top domains

Understand Neurimmune market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

Avg. visit duration in Neurimmune's top domains

Analyze Neurimmune engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown
neurimmune.comneurimmune.com00:01:36
See more with Sales Intelligence

Avg. pageviews on Neurimmune's top domains

See how Neurimmune keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

Want to gain deeper traffic insights?

Filter 20.3M+ online businesses. Discover new leads when their traffic spikes, when they start or stop using technologies, or when they get positive press.



Top technologies used by Neurimmune

These are the website technologies, by industry, used by Neurimmune top domains

Mobile (2)

Meta Viewport

Meta Viewport

Widget (2)

Google Maps

Google Maps

Advertising (1)

PubMatic

PubMatic

Audio Video Media (1)

Vimeo

Vimeo

More Technologies

4

See all

Ready to discover high quality prospects?

Identify what technologies a website uses to craft the perfect sales pitch, and shorten the sales cycle with the Similarweb Sales Intelligence Solution.


News & Signals from Neurimmune

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsNeurimmune Holding AG attends event 20th International Conference on Alzheimer's and Parkinson's Diseases.Neurimmune today announced its participation in the upcoming 20th International Conference on Alzheimer's and Parkinson's Diseases (AD/PD 2026) in Copenhagen, Denmark, from March 17 to March 21, 2026.
NewsNeurimmune Holding AG partners with Access AD.Neurimmune joins ACCESS-AD consortium, an innovative health initiative to accelerate timely and equitable AD diagnosis, treatment and care.
NewsNeurimmune Holding AG is developing NI009 for AL amyloidosis.Alexion (astrazeneca) and Neurimmune expand alliance to develop NI009 for AL amyloidosis.

See all Neurimmune signals

Focus your sales teams on the most promising opportunities. By prioritizing opportunities and engaging at the right time, you can optimize efforts and close more deals.